C. diff. Survivors Day Live-online Symposium Sponsored by Seres Therapeutic
Dr. McGovern is VP, Medical Affairs of Seres. Dr. McGovern has over 25 years of experience in infectious diseases. Prior to joining Seres, she served as Medical Director in the Medical Affairs Division at AbbVie and helped to launch Viekera Pak for treatment of Hepatitis C virus (HCV) infection. At AbbVie, Dr. McGovern was a recipient of the 2015 President’s Award in recognition of the successful execution of 7 major publications in the New England Journal of Medicine, Lancet, and JAMA. As an academic clinician at Tufts Medical Center, she also authored more than 50 journal articles, editorials, and textbook chapters on HIV and HCV and was an Associate Editor of Clinical Infectious Diseases and a Deputy Editor at Up-To-Date.
Dr. Feuerstadt attended the University of Pennsylvania where he earned his Bachelor of Arts degree in Biology, with distinction in research, and graduated Summa Cum Laude. Following the completion of his undergraduate training, Dr. Feuerstadt attended the Weill Medical College of Cornell University in Manhattan, New York where he earned his Medical Doctor degree and stayed at New York-Presbyterian Hospital/Weill Cornell medical center for his internship and residency in Internal Medicine. Following the completion of his residency, Dr. Feuerstadt then moved on to the Montefiore Medical Center in the Bronx, NY for his clinical fellowship training. His areas of interest include ischemic diseases of the gut and chronic diarrheal syndromes with a specific focus on C.diff. infections. Dr. Feuerstadt is affiliated with the St. Raphael campus of Yale-New Haven Hospital, Yale-New Haven Hospital, and Milford Hospital seeing outpatients in his offices in Hamden & Milford, CT
Dr. Boules, MD is Medical Director, Gastroenterology, Medical Affairs at Takeda Pharmaceuticals. Background: General Surgery Resident and Research Fellow Dept. of Gastroenterology & Hepatology at Cleveland Clinic. Topic expert and professional expertise in Gastroenterology and Gut Microbiome. Dr. Boules is a graduate of Alexandria University, Faculty of Medicine.
Dr. Khanna, M.B.B.S., M.S., is a Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic, Rochester, MN. His research and clinical interests include Epidemiology, Outcomes, and Emerging Therapeutics for Clostridium difficile infection, an arena in which he has had numerous publications and presentations. He is directing the C. difficile Clinic, Fecal Microbiota Transplantation program, and C. difficile related Clinical Trials at Mayo Clinic, Rochester, MN.
Dr. Chopra, MD,MPH,FACP,FIDSA,FSHEA Associate Professor of Medicine, Division of Infectious Diseases, Corporate Medical Director, Infection Prevention, Epidemiology, and Antibiotic Stewardship DMC and WSU Director, Infection Prevention, Epidemiology and Antibiotic Stewardship, Vibra Hospital
Paul Plumb is the Head of Clinical Recruitment at Rebiotix, a Ferring company. He specializes in investigator engagement, cross-functional collaboration and clinical trial acceleration.
Mr. Plumb has over 35 years of medical technology and healthcare delivery experience, wholly focused on emerging and leading-edge therapeutics, investigational drug and device development, and early stage commercialization. Paul describes
C. difficile infection research as the most rewarding work of his career; especially in the context of this life-threatening and cruel disease that causes great suffering.
C. diff. Survivor
Danelle James has an MD from Pennsylvania State University and a Master in Advanced Studies of Clinical Research from University of California San Diego (UCSD). She completed her Internal Medicine residency and Hematology/Oncology fellowship at UCSD, was Board Certified/Eligible in Internal Medicine and in Hematology and medical oncology.